Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does VALGANCICLOVIR Cause Pseudomonas infection? 64 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 64 reports of Pseudomonas infection have been filed in association with VALGANCICLOVIR (VALGANCICLOVIR). This represents 0.8% of all adverse event reports for VALGANCICLOVIR.

64
Reports of Pseudomonas infection with VALGANCICLOVIR
0.8%
of all VALGANCICLOVIR reports
25
Deaths
43
Hospitalizations

How Dangerous Is Pseudomonas infection From VALGANCICLOVIR?

Of the 64 reports, 25 (39.1%) resulted in death, 43 (67.2%) required hospitalization, and 14 (21.9%) were considered life-threatening.

Is Pseudomonas infection Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for VALGANCICLOVIR. However, 64 reports have been filed with the FAERS database.

What Other Side Effects Does VALGANCICLOVIR Cause?

Off label use (1,882) Cytomegalovirus infection (1,091) Drug ineffective (886) Neutropenia (809) Leukopenia (574) Drug resistance (524) Cytomegalovirus viraemia (447) Pancytopenia (434) Cytomegalovirus infection reactivation (374) Death (359)

What Other Drugs Cause Pseudomonas infection?

TACROLIMUS (744) PREDNISONE (649) MYCOPHENOLATE MOFETIL (604) RITUXIMAB (439) CYCLOPHOSPHAMIDE (427) METHYLPREDNISOLONE (417) PREDNISOLONE (394) METHOTREXATE (365) DEXAMETHASONE (352) CYCLOSPORINE (324)

Which VALGANCICLOVIR Alternatives Have Lower Pseudomonas infection Risk?

VALGANCICLOVIR vs VALIUM VALGANCICLOVIR vs VALPROATE VALGANCICLOVIR vs VALPROIC ACID VALGANCICLOVIR vs VALPROMIDE VALGANCICLOVIR vs VALSARTAN

Related Pages

VALGANCICLOVIR Full Profile All Pseudomonas infection Reports All Drugs Causing Pseudomonas infection VALGANCICLOVIR Demographics